Literature DB >> 9266501

Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane.

J M Villalba1, F Navarro, C Gómez-Díaz, A Arroyo, R I Bello, P Navas.   

Abstract

Cytochrome b5 reductase purified from liver plasma membrane reduces coenzyme Q (CoQ) in reconstituted liposomes in the absence of cytochrome b5. Both CoQ and its reductase are responsible for the reduction of the ascorbate free radical at the cell surface. Thus, NADH-CoQ reductase represents a partial reaction of NADH-AFR reductase in the plasma membrane. Cytochrome b5 reductase maintains CoQ and ascorbate in their reduced state to support antioxidations. Reduced CoQ prevents lipid peroxidation in liposomes and plasma membranes. Also, oxidized CoQ can prevent lipid peroxidations in the presence of cytochrome b5 reductase and NADH. Addition of CoQ to intact cells prevents serum withdrawal-induced lipid peroxidation and apoptosis. The prevention of apoptosis by CoQ is independent of the bcl-2 protein content in the cell. Antioxidants that act at the plasma membrane as CoQ and ascorbate would represent a first barrier to protect lipids from oxidative stress and subsequent apoptosis. Cytochrome b5 reductase is then an enzyme leading this function at the plasma membrane. These data support the idea that when the plasma membrane barrier fails, bcl-2 protein would be required to prevent cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266501     DOI: 10.1016/s0098-2997(97)00015-0

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  23 in total

1.  Ex-Vivo Normothermic Limb Perfusion With a Hemoglobin-Based Oxygen Carrier Perfusate.

Authors:  Sayf A Said; Carlos X Ordeñana; Majid Rezaei; Brian A Figueroa; Srinivasan Dasarathy; Henri Brunengraber; Antonio Rampazzo; Bahar Bassiri Gharb
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

2.  Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells.

Authors:  H Zhu; H Qiu; H W Yoon; S Huang; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Molecular basis of two novel mutations found in type I methemoglobinemia.

Authors:  Felipe R Lorenzo; John D Phillips; Roberto Nussenzveig; Bindu Lingam; Parvaiz A Koul; Stanley L Schrier; Josef T Prchal
Journal:  Blood Cells Mol Dis       Date:  2011-02-24       Impact factor: 3.039

Review 4.  Oxidative stress modulation in hepatitis C virus infected cells.

Authors:  Sonia A Lozano-Sepulveda; Owen L Bryan-Marrugo; Carlos Cordova-Fletes; Maria C Gutierrez-Ruiz; Ana M Rivas-Estilla
Journal:  World J Hepatol       Date:  2015-12-18

Review 5.  How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo.

Authors:  Henry J Forman; Kelvin J A Davies; Fulvio Ursini
Journal:  Free Radic Biol Med       Date:  2013-06-06       Impact factor: 7.376

6.  Transcriptional and translational mechanisms of cytochrome b5 reductase isoenzyme generation in humans.

Authors:  A Leroux; L Mota Vieira; A Kahn
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

7.  Plasma membrane redox and control of sirtuin.

Authors:  Frederick L Crane; Hans Low
Journal:  Age (Dordr)       Date:  2005-12-10

8.  Hydrogen peroxide- and cell-density-regulated expression of NADH-cytochrome b5 reductase in HeLa cells.

Authors:  Rosario I Bello; Francisco J Alcaín; Consuelo Gómez-Díaz; Guillermo López-Lluch; Plácido Navas; José M Villalba
Journal:  J Bioenerg Biomembr       Date:  2003-04       Impact factor: 2.945

9.  Vitellogenin recognizes cell damage through membrane binding and shields living cells from reactive oxygen species.

Authors:  Heli Havukainen; Daniel Münch; Anne Baumann; Shi Zhong; Øyvind Halskau; Michelle Krogsgaard; Gro V Amdam
Journal:  J Biol Chem       Date:  2013-07-28       Impact factor: 5.157

10.  Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis.

Authors:  Mukaddes Esrefoglu
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.